Valens SVP exercises options, sells 2,384 shares

Valens Semiconductor SVP, R&D Chairman David exercised stock options and sold the resulting shares in a pre-planned trade.

Rhea-AI Filing Summary

Valens Semiconductor SVP, R&D Chairman David exercised stock options and sold the resulting shares in a pre-planned trade. On April 16, 2026, he sold 2,384 Ordinary Shares at a weighted average price of $1.5049 per share, following the exercise of stock options at $0.86 per share.

The sale was made under a Rule 10b5-1 trading plan adopted on August 16, 2024. After the transactions, he held 403,968 Ordinary Shares directly and had 91,695 stock options remaining, exercisable until June 9, 2031.

Insider Trade Summary 10b5-1

Exercise and Sale: 2,384 shares ($2K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Chairman David

Role SVP, R&D

Sold 2,384 shs ($4K)

Approx. gross sale proceeds $4K

Approx. exercise cost $2K

Approx. pre-tax spread $2K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,384	$0.00	$0.00
Exercise	Ordinary Shares	2,384	$0.86	$2K
Sale	Ordinary Shares	2,384	$1.5049	$4K

Holdings After Transaction: Stock Option (Right to Buy) — 91,695 contracts (Direct); Ordinary Shares — 403,968 shares (Direct)

Footnotes (5)

1. F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
2. F2. The shares were acquired upon the exercise of stock options
3. F3. The shares sold were acquired upon the exercise of stock options on the same date
4. F4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
5. F5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Key Figures

Shares sold: 2,384 shares Sale price: $1.5049/share Exercise price: $0.86/share +4 more

7 metrics

Shares sold 2,384 shares Ordinary Shares sold on April 16, 2026

Sale price $1.5049/share Weighted average sale price for Ordinary Shares

Exercise price $0.86/share Stock option exercise price for 2,384 shares

Shares owned after 403,968 shares Direct Ordinary Share holdings following transactions

Options remaining 91,695 options Stock options outstanding after the exercise

10b5-1 plan adoption date August 16, 2024 Date insider adopted Rule 10b5-1 trading plan

Option expiration June 9, 2031 Expiration date for remaining stock options

Key Terms

Rule 10b5-1 trading plan, stock options, weighted average price, Stock Option (Right to Buy), +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

stock options financial

"The shares were acquired upon the exercise of stock options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) reported as a derivative security"

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Valens Semiconductor (VLN) insider Chairman David do in this Form 4?

Chairman David, SVP of R&D at Valens Semiconductor, exercised stock options and sold 2,384 Ordinary Shares. The sale followed an option exercise and was executed under a pre-arranged Rule 10b5-1 trading plan adopted in August 2024.

How many Valens Semiconductor (VLN) shares did the insider sell and at what price?

He sold 2,384 Ordinary Shares at a weighted average price of $1.5049 per share. These shares were acquired the same day through option exercises, so the transaction reflects an exercise-and-sell pattern rather than a simple open-market liquidation.

What option exercise activity did Valens Semiconductor (VLN) report for this insider?

He exercised stock options covering 2,384 Ordinary Shares at an exercise price of $0.86 per share. A related derivative entry shows 2,384 options converted into Ordinary Shares, reducing the option balance while increasing directly held shares before the same-day sale.

How many Valens Semiconductor (VLN) shares does the insider own after these transactions?

After the reported transactions, Chairman David directly held 403,968 Ordinary Shares. This figure shows his remaining equity stake following the 2,384-share sale linked to the option exercise on April 16, 2026.

Does the Valens Semiconductor (VLN) Form 4 mention a Rule 10b5-1 trading plan?

Yes. A footnote states the sales were effectuated under a Rule 10b5-1 trading plan adopted on August 16, 2024. Such plans pre-schedule trades, indicating the timing of this sale was set in advance rather than decided opportunistically.

What stock options remain for the Valens Semiconductor (VLN) insider after this filing?

The derivative table shows 91,695 stock options remaining after the 2,384-share exercise. These options carry an exercise price of $0.86 per share and are scheduled to expire on June 9, 2031, providing continued potential equity exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 08:22 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chairman David

(Last) (First) (Middle)

42 HOLOT GEULIM

(Street)

ZORAN

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/16/2026		M(1)		2,384(2)	A	$0.86	406,352	D
Ordinary Shares	04/16/2026		S(1)		2,384(3)	D	$1.5049(4)	403,968	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.86	04/16/2026		M(5)			2,384	06/01/2022	06/09/2031	Ordinary Shares	2,384	$0	91,695	D

Explanation of Responses:

1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024

2. The shares were acquired upon the exercise of stock options

3. The shares sold were acquired upon the exercise of stock options on the same date

4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.

5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

	David Chairman by: Oppenheimer Israel, as Attorney-in-fact	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)